- Home
- FRO vs ALKS Comparison
FRO vs ALKS Comparison
Compare FRO & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FRO
- ALKS
- Stock Information
- Founded
- FRO 1985
- ALKS 1987
- Country
- FRO Cyprus
- ALKS Ireland
- Employees
- FRO N/A
- ALKS N/A
- Industry
- FRO Marine Transportation
- ALKS Biotechnology: Pharmaceutical Preparations
- Sector
- FRO Consumer Discretionary
- ALKS Health Care
- Exchange
- FRO Nasdaq
- ALKS Nasdaq
- Market Cap
- FRO 4.5B
- ALKS 5.1B
- IPO Year
- FRO N/A
- ALKS 1991
- Fundamental
- Price
- FRO $20.91
- ALKS $28.97
- Analyst Decision
- FRO Strong Buy
- ALKS Strong Buy
- Analyst Count
- FRO 3
- ALKS 13
- Target Price
- FRO $25.00
- ALKS $40.38
- AVG Volume (30 Days)
- FRO 2.3M
- ALKS 1.3M
- Earning Date
- FRO 08-29-2025
- ALKS 10-23-2025
- Dividend Yield
- FRO 8.52%
- ALKS N/A
- EPS Growth
- FRO N/A
- ALKS 21.99
- EPS
- FRO 1.07
- ALKS 2.08
- Revenue
- FRO $1,729,768,000.00
- ALKS $1,505,296,000.00
- Revenue This Year
- FRO N/A
- ALKS N/A
- Revenue Next Year
- FRO $14.48
- ALKS $1.66
- P/E Ratio
- FRO $13.25
- ALKS $13.97
- Revenue Growth
- FRO N/A
- ALKS N/A
- 52 Week Low
- FRO $12.40
- ALKS $25.56
- 52 Week High
- FRO $25.68
- ALKS $36.45
- Technical
- Relative Strength Index (RSI)
- FRO 64.04
- ALKS 54.99
- Support Level
- FRO $19.87
- ALKS $28.77
- Resistance Level
- FRO $20.88
- ALKS $29.39
- Average True Range (ATR)
- FRO 0.51
- ALKS 0.71
- MACD
- FRO 0.15
- ALKS 0.13
- Stochastic Oscillator
- FRO 94.30
- ALKS 70.54
About FRO Frontline Plc
Frontline PLC is an international shipping company engaged in the seaborne transportation of crude oil and oil products. Group operates through the tankers segment. The tankers segment includes crude oil tankers and product tankers. Its geographical area of operation includes Arabian Gulf, West African, the North Sea, and the Caribbean. Frontline earns revenue through voyage charters, time charters, and a finance lease. It is also involved in the charter, purchase, and sale of vessels.
About ALKS Alkermes plc
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.